家族性IgA肾病终身ESRD风险显著增高
该研究纳入348例家族性IgA肾病患者(来自167个家系)与1116例散发性患者比较,发现校正性别后家族性患者终身ESRD风险显著更高(HR=1.40,95%CI 1.12-1.74,P=0.004),中位ESRD年龄提前5年(60岁 vs 65岁)。家族性患者中单代家系及早发(<30岁)者风险进一步升高,且性别差异消失。
要点
- 家族性IgA肾病终身ESRD风险较散发性高40%,ESRD年龄提前5年。
- 单代家系及发病年龄<30岁者ESRD风险更高。
- 家族性患者中未见散发性患者存在的性别差异。
核心结论
- 家族性IgA肾病较散发性预后更差,代表一种进展更快的独特亚型。
- 早期诊断可能改善家族性IgA肾病患者的预后。
研究设计与样本
- 回顾性比较研究,纳入348例家族性IgA肾病(来自167个独立家系)与同地区1116例散发性IgA肾病患者。
主要发现
- 校正性别后家族性患者终身ESRD风险显著高于散发性(HR=1.40,95%CI 1.12-1.74,P=0.004)。
- 家族性患者中位ESRD年龄为60岁,散发性为65岁,提前5年。
- 家族性患者中,单代家系较多次代家系ESRD风险更高(HR=2.62,95%CI 1.59-4.31,P<0.001)。
- 家族性患者中,早发(<30岁)较晚发ESRD风险更高(HR=4.79,95%CI 3.16-7.26,P<0.001)。
- 散发性患者中男性终身ESRD风险高于女性(25% vs 17%,P=0.003),家族性患者中未见此性别差异。
临床怎么用
- 对家族性IgA肾病患者应加强监测与早期干预,尤其单代家系及早发患者。
- 家族性IgA肾病患者性别差异不明显,临床评估不应仅依据性别判断风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Familial IgA nephropathy (IgAN) has been widely reported. However, its clinicohistologic characteristics and long-term prognosis are not clear. METHODS: A total of 348 familial IgAN cases from 167 independent families were recruited and their clinicohistologic characteristics as well as lifetime risk of end-stage renal disease (ESRD) were compared to 1116 sporadic IgAN patients from the same geographic region. RESULTS: Of all familial IgAN patients, 60 (17%) came from 32 single-generation (SG; all affected individuals are siblings) families, whereas 286 (82%) came from 134 multiple-generation (MG; affected individuals were present in at least 2 consecutive generations) families. The lifetime ESRD risk was significantly higher in familial patients than sporadic ones after adjusting by gender (hazard ratio [HR]=1.40, 95% confidence interval [CI]: 1.12-1.74, P = 0.004), with 5 years younger in median ESRD age (60 years vs. 65 years in familial and sporadic cases separately). Interestingly, among familial patients, we found cases from SG families (vs. MG families: HR = 2.62, 95% CI: 1.59-4.31, P < 0.001) or with early onset (onset age <30 years) (vs. late onset: HR = 4.79, 95% CI: 3.16-7.26, P < 0.001) had higher lifetime ESRD risk. Furthermore, among sporadic patients, men had lower estimated glomerular filtration rate (eGFR), higher urine protein, higher Oxford T score, and higher risk for life span ESRD compared with women (male vs. female, 25% vs. 17%, P = 0.003) whereas these gender differences were not seen in familial patients. CONCLUSION: Familial IgAN cases had poorer renal outcomes and less gender differences compared with sporadic cases. These findings provide evidence that familial disease represent a distinct subtype of more progressive IgAN. Early diagnosis could improve the prognosis of cases with familial IgAN.
引用
- Shi M, Yu S, Ouyang Y, et al. Increased Lifetime Risk of ESRD in Familial IgA Nephropathy. Kidney Int Rep. 2020. PMID: 33426388. doi:10.1016/j.ekir.2020.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。